Cost per new patient is climbing — med spas

Cost per lead is falling and cost per sold treatment is not

PRESENTATION — WHAT THE OPERATOR SEES

Cost per lead is down quarter over quarter, the media report reads well, and revenue per clinic is flat. Nobody in the room can say what a booked consult costs, and nobody can say what a sold treatment costs. Before diagnosing anything, establish which business is presenting: laser packages, injectables, body contouring and membership have four different economics and are almost always reported on one blended number.

DIFFERENTIAL — LIKELY CAUSES, MOST LIKELY FIRST

01
The denominator is a lead, not a booked consult

A lead is an inquiry. The money is decided between the inquiry and a kept consult — how fast the call went out, whether the slot offered was one the patient could take, whether anybody called back on a Saturday. Cost per lead can fall for a whole year while cost per sold treatment rises, because the leads arriving are cheaper and worse.

There is no figure to quote here and that is the finding. No cost-per-consult or cost-per-sold-treatment distribution is published for this category by anybody without media to sell, so the only honest denominator is the group's own instrumented baseline.

No published distribution — ADMEN source register, /sources/

NOT THIS IF — You already report cost per booked consult and cost per sold treatment, per clinic and per service line, and all three moved in the same direction.
02
Four service lines are being charged one blended acquisition cost

Laser hair removal is a high-ticket package sold once, often against a payment plan, to a patient who may never buy again. Injectables are a repeat cycle where almost none of the value is in the first appointment. Body contouring is one high-ticket close after a long consideration period. Membership is a retention business wearing an acquisition costume. Blended, the repeat line is charged the full cost of a patient it will keep for years and the one-off line is charged nothing for the fact that the patient does not come back.

Every one of the four lines is separable in the group's own point-of-sale and booking data. The absence is in the reporting, not in the data.

No published distribution — ADMEN source register, /sources/

NOT THIS IF — Acquisition cost is already reported per service line and the rise is confined to one of them.
03
Discount-led acquisition is selecting for a patient who does not return

A promotional calendar buys the patient who came for the promotion, and that patient leaves for the next one. The acquisition cost is then paid again on every visit, which shows up as a rising blended cost with no change in media price at all.

Discount share of revenue — what proportion of the book was bought on promotion — is readable in any point-of-sale system and is almost never in the reporting pack. It predicts next year's margin more reliably than this year's cost per lead does.

No published distribution — ADMEN source register, /sources/

NOT THIS IF — Discount share of revenue is flat year over year and repeat purchase rate held or improved.
04
Clinics still in their ramp are dragging the network average

A new clinic carries full acquisition cost against immature volume. Pooled into a network average, a group opening sites faster than it matures them will read as a media price rise every quarter, and the rise will be mechanical rather than a failure.

No new-clinic ramp curve is published for this category. Every operator has an internal view of how long a site takes to reach maturity and very few can say what drives the variance between the site that got there early and the site that never did.

No published distribution — ADMEN source register, /sources/

NOT THIS IF — Mature-clinic cost per sold treatment rose on its own, with de novo sites excluded from the population.
05
Consultant-level conversion variance, priced as media

The sale is closed in the room. Two clinics forty miles apart on identical media, identical pricing and an identical offer, converting at materially different rates, are describing a consultant problem — and it arrives at the finance meeting as a cost-per-acquisition problem because that is the only place it is measured.

Consultant-level close rate is a real number, it is in the booking system, and in most groups nobody has ever run it. The group's best closer is a person rather than a process until it is.

No published distribution — ADMEN source register, /sources/

NOT THIS IF — Close rate by consultant has been measured for at least two quarters and sits inside a narrow band across the group.

HOW TO TELL THEM APART

How to tell these apart in your own numbers

Each of these is a measurement you can run yourself, without us.

01 · The denominator is a lead, not a booked consult

Rebuild the cost line three ways for the same period, per clinic: spend over leads, spend over booked-and-kept consults, spend over sold treatments. Spend means the ledger — media, agency fees, promotional discount and consult incentives — not the ad dashboard.

CONFIRMS IF

Cost per lead fell while cost per booked consult or cost per sold treatment rose.

EXCLUDES IF

All three moved in the same direction by a similar proportion. The change is a real price change and belongs to the media.

02 · Four service lines are being charged one blended acquisition cost

Split the same three cost lines by service line — laser, injectable, body, membership — for twelve months, per clinic.

CONFIRMS IF

One line is carrying the average and the others are inside their own trailing range.

EXCLUDES IF

All four lines rose together and by a similar proportion.

03 · Discount-led acquisition is selecting for a patient who does not return

Discount share of revenue by month, and repeat purchase rate and time to second purchase for patients acquired on promotion against patients acquired at list price.

CONFIRMS IF

The promotional cohort repeats materially less often, or discount share of revenue is climbing.

EXCLUDES IF

The two cohorts repeat at similar rates and discount share is flat.

04 · Clinics still in their ramp are dragging the network average

Recompute cost per sold treatment on mature clinics only — sites open long enough to have reached whatever the group's own definition of maturity is — and compare it against the pooled network figure.

CONFIRMS IF

The mature-only figure is flat or improving while the pooled figure rises.

EXCLUDES IF

The mature-only figure rose too.

05 · Consultant-level conversion variance, priced as media

Consult-to-sold rate by individual consultant, twelve months, with volume beside it so a small denominator is visible.

CONFIRMS IF

The spread between consultants is wider than the spread between clinics.

EXCLUDES IF

Consultants inside a clinic converge and the clinics differ — then the finding is local, not personal.

WHAT RESOLVES EACH

What resolves this, and how you will know it resolved

The denominator is a lead, not a booked consult	Rx 04 · marketing attribution →	Rebuild the cost line on a booked-consult and sold-treatment denominator, per clinic and per service line, tied to the ledger rather than to the ad dashboard. What does not work: cutting media. Cutting a media budget measured on the wrong denominator changes the number without changing the business.
Four service lines are being charged one blended acquisition cost	Rx 04 · marketing attribution →	Four separate acquisition-cost lines from the first month, never pooled to a network average.
Discount-led acquisition is selecting for a patient who does not return	Rx 01 · patient acquisition →	Move demand off promotion and onto the service lines that repeat, and price the promotional calendar against repeat rate rather than against sign-ups.
Clinics still in their ramp are dragging the network average	Rx 04 · marketing attribution →	Report new clinics against a ramp curve of their own, and mature clinics against each other. Two populations, never one average.
Consultant-level conversion variance, priced as media	Rx 03 · patient conversion →	Consultant-level close rate reported so it can be coached, with the offer, the financing and the follow-up sequence treated as part of the funnel rather than as sales-team business.

WHAT "RESOLVED" LOOKS LIKE — Cost per sold treatment, per clinic, per service line

MEDIAN

Not published. No med spa acquisition-cost distribution exists from any source that is not selling marketing services.

TOP DECILE

Not published, and for the same reason. A vendor with a product to sell is not a denominator.

TARGET

Your own instrumented baseline, rebuilt on the sold-treatment denominator and read per service line. Resolved means the mature-clinic figure is flat or falling while sold volume rises, and that the four lines are being priced separately.

No published distribution — ADMEN source register, /sources/

HOW THIS DIFFERS BY SCALE

How this differs by scale

Single site	One clinic, one consultant roster. The denominator problem is the whole problem here — a single room can measure consult-to-sold by hand in an afternoon.
Group	Nine sites is roughly where the network average starts hiding the two clinics that are losing money, and it is roughly the average size of the multi-location aesthetics groups this is written for. This is the scale at which per-clinic, per-line reporting stops being nice and starts being the deliverable.
Platform	At platform scale the acquisition-cost line is being read by somebody who did not buy the media, and the ramp population has to be separated before the number means anything at all.

OTHER PRESENTATIONS — MED SPA & AESTHETICS

A differential narrows the field. It does not replace the examination — that is what the six weeks are for. Every figure above is an industry reference range, not a client's numbers; those stay sealed. Sources are set out at /sources.

APPLY — 6 / QUARTER →